Still sceptical about the benefits of prophylactic statins?
In spite of the many advances in medical science that have resulted in a steady reduction in deaths from cardiovascular disease in most European countries, CVD remains the leading cause of mortality in Europe. Without appropriate interventions, the effects of an ageing population, together with the increasing prevalence of obesity and Type 2 diabetes, can […]
